The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab od Pascal Gasser, Svetlana S. Tarchevskaya, Pascal Guntern, Daniel Brigger, Rahel Ruppli, Noemi Zbären, Silke Kleinboelting, Christoph Heusser, Theodore S. Jardetzky, Alexander Eggel

Preuzmi cijeli tekst